Although the host response to gram-negative bacterial infection follows largely from the interactions of bacterial lipopolysaccharides (LPS or endotoxin) witb host cells, little information is available concerning the mechanisms by which the host eliminates or detoxifies LPS, AcyloxyacyJ hydrolase (AOAH) is an enzyme, found in phagocytic cells. that catalyzes the enzymatic deacylation of the lipid A moiety of LPS. Enzymatically deacylated LPS is much Jess potent than LPS at inducing responses in human cells, and it can antagonize the ability of LPS to activate human macrophages, neutrophils, and endothelial cells, Despite these observations, the physiologic role of LPS deacylation remains undefined. To invest.igate the ability of AOAH to carry out LPS deacylation in vivo, we produced a recombinant adenovirus carrying a gene encoding AOAH (Ad.CMV·AOAH) and employed Ihis vector to elicit transient overexpression of AOAH in mice. Mice infected witb Ad.CMV AOAH expressed high levels of the enzyme in plasma, liver, spleen, and kidney. Although adenovirus·induced hepatitis reduced hepatic uptake of intravenously injected [3H]LPS, animals expressing the transgeue deacy lated a larger fraction of the [3H]LPS taken up by their livers tban did mice infected with a control adenovirus. These studies indicate that AOAH can catalyze the deacylation of LPS in vivo, and they provide evidence that the rates of hepatic LPS uptake and deacylation are not closely linked.
The capacity of hOSl phagocytic cells to activate in response to bacterial lipopolysaccharide (LPS or endotoxin) is an im portant defense against gram-negative bacterial infeetion. This aetivation is triggered largely hy interactions of the lipid A moiety of LPS with critical host eells, mediated by binding LPS lo cellular CD14. Allhough much has been learned reeently about host systems for recognizing and responding to LPS, relatively little is known about the meehanisms by which LPS is detoxified in vivo. Sinee an excessive response to LPS may have deleterious effects culminating in the syndrome of septic shock, there is substantial medical interCSl in these mechanisms and in the development of strategies to limit the host response to LPS.
Previous studies from this laboratory have explored the po tential endotoxin-detoxifying role of acyloxyacyl hydrolase (AOAR) , a phagocytic cell enzyme that removes secondary acyl chains from the lipid A moiety of LPS (11) . Enzymatically deacylated LPS (dLPS) is 10o-fold less potent than LPS at eliciting the dermal Shwartzman reaction in rabbits (22) . In vitro, dLPS is also substantially less active than LPS at stimu lating human monocytes, neulrophils, and endothelial cells (25) . Moreover, it eompetitively inhibits binding of LPS to CD14 at concentrations near its binding K d (14) and potentJy antagonizes the ability of LPS to stimulate NF-KB binding activity and interleukin 1 and interleukin 8 release from human cells (14, 15) . Enzymatic deacylation of LPS by AOAR might thus function both to detoxify LPS and to generate an LPS antagonist in humans.
While the activily of AOAH and the effects of dLPS have been characterized in cultured cells, the function(s) of AOAH in vivo has not been examined previously. One approach to cvaluating the biological role of a moleeule is to examine thc eonsequences of increasing its abundance. This may be aecom plished by directly administering thc molecule to animals, by creating transgenic animals that overexpress it, or by tran sicntly overexpressing a gene that encodes it following in vivo gene transfer. To investigate the role of AOAH, we con structed a rccombinant adenovirus carrying a gene in which a cDNA coding for human AOAH is expressed from the human cytomegalovirus immediate-early promoter-enhancer (Ad. CMV-AOAH). On the basis of our prior observations of for eign gene expression following systemic administration of re combinant adenoviruses (12, 17, 26) , we antieipated that intra venous administration of lhis recombinant adenovirus to mice would result in transient, constitutive overexpression of the human enzyme in the liver. Since the liver is the principal site of uptake of LPS from the circulation, we reasoned that he patic overexpression of AOAH migh! accelerate LPS deacyla tion. In addition, if hepatically synthesized AOAR were re leased into the circulation, interaction of AOAH with circulating LPS might alter LPS clearance from the plasma space. Since both dLPS (22) and other tetraacyllipid A analogs (8, 18 ) retain much of the potency of LPS in mice, on the other hand, AOAH overproduction would not be expected to protect mice against LPS challenge.
We now describe experiments demonstrating that intrave nous administration of Ad.CMV-AOAH to mice results in striking increases in AOAH activity in the liver, spleen, and kidney and that overexpression of AOAH in the liver produces a proportional increase in the rate at which intravenously ad ministered ['H]LPS undergoes hepatic deacylation. Overex pression of AOAH also increased enzyme activity in plasma. yet the deacylation of f'HJLPS in the plasma space was not enhanced and the rates of clearance of rough-and smooth form LPS from the plasma space were not altered.
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MATERIALS AND METHODS
Reagents. Chemicals were purchased from Sigma Chemical Co. (SI. Louis, Mo.) unless otherwise slated. All solutions were prepared in baked glassware wllh pyrogen-lree waler (Baxter Heallhcarc, Deerfield. 111.). and tissue cui lure med)~ u;seu Ln virus pre::paraliun wert:. pl"e~(:Ire<.J b'y us: of luw-endoloxlO rc~aJ hOVlnc serum (HyClone, Logan, Utah). I H, I4CJLP~, useu as subslral. lor enZyme assays, was prepared from Snlmondla typhmmrillm as described previ ously (21) . Rough I'II)LPS wa. prepared Jrom f:;;c!lcndllo col, LCD25 (2U): lIS speellic actiVlCY was 2 x JU' dpm/lJ,g. Smooth (O-antigen-containing) l'II]LPS was prepared from S l)'Phllmll'l1llll G-30, grown in the presence 01 (i) I'Hlacetate and LO mM D-galaetose (II) or (ii) ,'Hlgalactnse and 0.05 mM nonradloaelive D-galaclOse (23). The smo<>lh LPS were isnlated hy 'Iandard phennl-warer ex lraCllOn followed by extensjve elher washes 10 remove ront,lmmaling phospho lipids (2J). Thelf specific acLivilies were 2,UOO aud 75,000 dpm/lJ,g, respectively.
Preparation of recombinanf adenoviruses. The recombinant adenOVirus Ad.
CMV-AOAH was generated by homologous recombmallon beTWeen sub S!t:-numk fragmcnl$ of a mudHleJ i:ldcnovilus g~nom.: In 293 cell.') 'dS desuiht::d previously 0). Briefly, a full-length eDNA enroding hnman AOAH (W) was subdoned into the plasmid pACCMV.pLpA (7) , and the resuillng plasm,u (l0 IJ,~) wa" (olranslecteu IOto 29.' cell; with 5 )Lg 01 Xbrrl-dtgcslcu ADuB09 DNA hy calcium phosphate copre(tpilalion wil h a glycerol shock to hoosl lranslection efficicn~:y. Homolngous recomhinannn nelween the pAC rla~mid and the right 91 % fragment of the viral genome resulted in the [ormal;on of a recombiuant viral genome of packageable SIZe in which the CMV-AOAH fnsion gene replaces lhe nallve adenovirus early reeion 1.
Clonally derived recombinant virnses were isola led and propagated as de sCtlhe.u pre'lOusly (17) Smonth LPS clearance Irnm pla'ma wa.' determined 4 dap. t'nllowmg mJeCllnn of i X 10" lO 2 X 10') rFU of Ad,CMV·AOAH, Ad.CMV-j3Gal. or saHne. Mice were bled al5 min, 60 min, or 6 h aHer iutravenous injeelion of eilher 100 ~.g of smooth ['Hlaeetate-Iabclecl LI'S (rwo experiments) or 5 )J.g of (-'UlgalaelOse labeled LPS (one e><periment), and the plasma LPS eoneelHralions were ex prcsscu as a pcrc~ntdgt "I' ~he inillal plasma l 'HjLPS concentration as described d~lOVc.
In the rough and the I'HJaeetate-laheled smooth LPS, essentially all ollhe 'H dlSlntcgrations pcr minntc arc In fany acyl chains (20) . I'JIjLPS dcacylation iu liver nr plasma was delermlned by mcasunng Ihe IOta I anu ethanol-soluble 'II.
Thlety minutes aILer inlravenous InJcWon of I'HlLI'S, ahqnOls 01 liver homo genalc" in lysIS hulfer were mixed wilh ethann] (1 volume nl Iysale 10 ,volume, of ethanol), held al -20"C for 2 h, and lhen eenlClfuged (12,000 x g, lU min, 4°C). The 'H remaining in Ihe snpernalanl (I.e., no longer pan ohhc LPS, which is ethanol insoluble) was eounled. The lotal 'H in Ihe salliptes was also counled, and the fraellon of 'H 10 the ethanol supernalant.. was expressEd a, a percenlage. Uuder oplimal eoudilions. AOAH can remove approxir,nalely 30'1<. of Ihe 'H from 1~'HJLI'S (lWO 01 th~ six t'ally acyl chains io the LPS) DAt. analysis. Group dala were analyzed by An'dlySIS uf Vartance (Kwiksl.l VerslOu 4; TexaSofL. Dallas, Tex.) and the Newman-Keuls multIple comparison test. D,ft'erenees al the level of l' of <0.U5 were conSIdered slg",~cant. Relallon shjps between liver and plasma enzyme acilviues were examined hy Hnear re grc.loislon.
RESULTS
Mice injected intravenously with Ad.CMV-AOAH demon strated significant increases in AOAH activity in the liver, spleen, and kidney 3 to 4 days after infection (Fig. 1) . Enzyme aclivitv in liver tissue harvested from Ad.CMV-AOAH-in fectect' animals was more than 40-fold greater than that in lissue harvested from uninfected control animals and more than lO-fold greater than that in liver from animals infected with the irrelevant virus Ad.CMV-j3Gal. Notably, animals in fected with Ad.CMV-j3Gal showed a small hut significanl in crease in tissue AOAH activity over that of unirrfected control animals (Fig, 1) . Overexpression of AOAH in infected mice was associated with a significanl but transient increase in plasma AOAH ac tivity ( Fig. 2 and data not shown) . Three days after infection, plasma enzyme aetivity in Ad.CMV-AOAH-infected animals was 5-to 10-fold greater than that in uninfeeted or Ad.CMV f3Gal-infeeted eontrols. Plasma AOAH aetivity peaked 4 to 6 days after infection at levels more than 20-fold greater than those in uninfected controls. At 10 and 13 days after infeeljon, plasma AOAH activities were not significantly different from levels in animals infecled with the conlrol recombinant adeno virus. There was a strong correlation between plasma and liver AOAH activities in individual animals following infection with Ad.CMV-AOAH (n = 13 mice; r = 0.86, P = 0.0001).
LPS exists in two forms, S or smooth (O-antigen containing)
and R or rough (lacking 0 antigcn), which are cleared from plasma in different ways. While the fornler (like the LPS in intravenously injected bacteria [6] ) is initially cleared almost exclusively by phagocytie cells (KupfIer cells and iutravascular granulocytes), the latter is cleared principally by hepatocytes (3, 13) . Bccause systemic adminislration of recombinant ade novirus is associaled with preferential infection of hepatocytes (12), we examined the rate of deacylation of rough [3H)LPS to del.ermine whelher ovcrexpression of AOAH would increase the rate of intracellular LPS deacylalion in vivo. The LPS deacylation rate was determined by measuring the fraction of the radiolabel that appeared in an ethanol-soluble form in hepatic tissue harvested from saline, Ad.CMV-f3Gal-, and Ad. CMV-AOAH-injected animals 30 min following intravenous administration of rough-form [~H]LPS. As shown in Fig. 3A , infection of mice with Ad.CMV-AOAH resulted in a signifi cantly increased (approximately sixfold, P < 0.05) rate of he patic LPS deacylation in comparison with that of control ani mals. Similar results wcre found in another experiment (Table  1 ). In view of the fact rhat AOAH removes only two of the six acyl chains from the lipid A moiety of LPS, the observed release of 4 to 6% of the radiolabel from rough LPS over the 30-min study period is eonsistcnt with enzymatic deacylaUon of approximately 12 to 18% of the liver-associated LPS within this timc period. There was a positive correlation between the rate of in vivo hepatic deacylation of rough LPS and the assayed hepatic AOAH activity (Fig. 3B) . In contrast to the inereased rate of LPS deacylation pro duced by overexpressing AOAH in the liver, the accumulation of AOAH activity in plasma following infection of mice with Ad.CMV-AOAH was not associated with detectable in vivo deacylation of rough-form !,HJLPS in the plasma space; Le., ethanol-soluble ~H in plasma 30 min following administration of [3H]LPS was not increased in Ad.CMV-AOAH-infected mice, despite the presence of increased levels of assayable AOAH in plasma (data not shown). AJthough the rapid clear ance of rough-form LPS from the circulation allowed a rela tively brief time period for intravascular deacyJalion to Occur, accumulation of AOAH in plasma also did not significantly alter the rate of clearanec of smooth-form [3H)LPS from the plasma space (Fig. 4) or enhance its deacylation in plasma (data not shown). The unavailabilily of smooth LPS radiola beled to high specific aClivity in the acyl chains precluded a sensitive assessment of its deaeylation in vivo, however. An other potential explanation for low plasma deacylation rates could be the uptake of LPS-derived 'H-fatty acids from plasma by various tissues; the lack of correlation between plasma and liver ethanol-soluble 1H argues against this possibility.
While clearance of a small or large amount of smooth·form LPS was not altered hy overexpression of AOAH, we did observe that infection of mice with recombinant adenovirus per se altered the uptake of rough-form [ infected with either Ad,CMV-AOAH 0, Ad.CMV-~Gal dem onstraled noticeable splenic enlargement 3 to 4 days after infection, and spleen weights in both groups were significantly greater (by approximately 50%) than those in saline-injected controls (Table 1 ).
In the course of these experimeuts, several groups of animals were infected with Ad.CMV-AOAH. We obscrved consider able mouse-to-mouse variability in the levels of hepatic and Time after Lv. injection, min plasma AOAH activities, dcspite careful efforts to standardize the procedure for administration of virus (injections in any group were performed within 1 h by an experienced tcchnician with a single virus preparation and no observed loss of inocu lum). To invest.igate the cause of this interanimal variation, we performed several additional experiments. First, we measured hepatic AOAH expression in groups (11 = 11 to 13 per group) of male ICR (outbred) and BALB/c (inbred) mice. Both strains demonstrated simila, variability in hepatic AOAH ac tivilY (ranging from 3-to 21-fold belween the highest and lowcst producers in individual groups). Second, we infected ICR mice with an inoculum containing both Ad.CMV-AOAH (1.5 X lOy PFU) and Ad.CMV-Luc (a recombinant adenovirus carrying a gene encoding firefly luciferase; 0.25 x 10 9 PFU) and determined the activities of both enzymes in hepatic tissue 3 days after infection. We observed a strong correlation be tween the levels of AOAH and luciferase in hepatic tissue harvested from these animals (Fig. 5) . Finally, repeated exper iments with different batches of recombinant virus demon strated similar ranges of interanimal variation in the levels of expressed AOAH aetjvity. These experiments suggest that the variation in the levels of AOAH activity observed in the liver following administration of Ad.CMV-AOAH resulted from variability in the efficiency of hepatic infection rather than from virus-, barch-, recombinant protein-, or mouse strain related factors. Adenoviral infection might be affected by diet, 
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COULTHARD ET AL endotoxin absorption from the gut. subclinical infection, or other unmeasured variables.
DISCUSSION
The experiments describcd here demonstrate that human AOAR catalyzes the enzymatic deacylation of bacterial LPS in vivo and that introduction of a constitutivc gene encoding this enzyme into the liver in mice substantially enhances the rale at which rough-form LPS undergoes hepatic deacylation. With prior studies demonstrating that dLPS both competitively in hibits binding of LPS to CD14 (14) and interferes with other steps in the LPS signal transduction pathway to antagonize LPS-induced activation of human cells (14, 15) , overexpression of AOAR might be expected to exert a protective effeet against an excessive endotoxin response. In this regard, the present observations in mice are more cautionary than enthusiastic.
Our results suggest that the rates of tissue uptake and deacy lation of LPS are not tightly linked. Deacylation of intrave nously injected LPS normally occurs slowly in rodent livers (4), consistent with the low deacylation rates seen in control ani mals in this study ( Fig. 3 and Table 1 ). Although AOAH has not heen demonstrated in hepatocytes, LPS-deal;ylating activ ity has been described in these cells (5) . Overexpression of AOAR increased the rate of LPS deacylation in the liver severalfold, suggesting that enzymatic activity, rather than sub strate availability (i.e., the rate of LPS internalization), is rate limiting for deacylation. In fact, hepatie deacylation increased despite a faJl in the fractional hepatic uptake of the tracer (and thus an absolute reduction in [3HJLPS uptake), again suggest ing that, at least in hepatocyles, low enzymatic activity nor mally limits the rale of LPS deacylation. A similar rclationship may pertain to human neutrophils, which internalize LPS much morc rapidly than they deacylate it (19) . Enhancing intracellular LPS deacylation in hepatocytes or neutrophils should thus not interfere with LPS signals that are transduced from the cell surface, but it Blight diminish the ability of LPS to signal at intracellular sites or to stimulate other eells if exocytosed. Hepatic LPS degradation in vivo normally occurs very slowly over time (16) , and the longer-term consequences of accelerating this process have not heen explored.
When challenged intravenously with LPS, rabbits rapidly accumulate AOAR activity in plasma (2) . If AOAR deacylates LPS in plasma, the enzyme might be a host mechanism for avoiding the deleterious effects of endotoxemia. Although AOAH has substantial (approximately one-third of maximal) activity at pH 7.4 when assayed in a detergent-containing buffer system in vitro (11), it has not been possible to demon strate deacylation of LPS in near plasma or serum (2) . In the presenl experiments, we found that adenovirus-mediated transfer of the AOAH gene generated high levels of recombi nant AOAH in plasma. This accumulation of plasma AOAH, detected by its aetivity in the in vitro assay system. was not associated with demoustrable dcacylation of LPS in plasma, howevcr, suggesting that AOAH is not catalytically active to ward LPS in vivo in the plasma space. Similarly, the lack of a discernible effect on LPS clearance suggests that AOAR may not bind LPS in plasma. Highly purified LPS may not be the appropriate substrate for AOAH in vivo, however, wherc LPS is released from bacteria in membrane fragments that include prolein and phospholipid and where numerous other potential substrates for AOAH (which is also a phospholipase A [24] ) are present.
Although the adenoviral vector used for these experiments provided a convenient and effective mechanism for overpro ducing AOAR in mice, it also imposcd several important lim- itations. First, since the virus predominantly infects hepato cytes, it did nOl augment AOAH activity selectively in lhe phagocylic cells (neutrophils and monocytes/macrophages) that normally express the enzyme. (For example, fractional LPS deacylation was not enhanced in the spleens of mice that received Ad.CMV-AOAR [data not shown], despite greatly increased splenieAOAR activity [ Fig. 1 ).) Although we did not identify the adenovirus-infected cells in the spleen, they may not be the phagocytic cells that take up LPS). It is possible that overexpression of AOAH in phagocytic cclls could influence phenomena such as the persistenee of the in vivo response to LPS, LPS adjuvanlicity, endotoxin tolerancc, and chronic LPS induced inflammation. Second, adenoviral infection induces an inflammatory response that, as shown here, produces hepatitis and splenomegaly, alters lhe tissuc distribution of intrave nously injected LPS, and induces low-level increases in AOAR act.ivity. Third, substantial heterogeneity in adenovirus-medi ated recombinant protein expression was found even in inbred mice. Such variability, while anticipated in any biological sys tem, greatly increases the numbers of animals needed to study the impact of recombinant protein expression on a phenome non, sueh as LPS-induced inflammalion, (hal is itself highly variable in its severity.
While the activity of AGAR and [he effects of dLPS have been charaelerized in cultured cclls. potential function(s) of LPS deacylation in vivo have not been examined previously. These studies showcd that mice infected with a recombinanl adenovirus carrying a constitutive AOAR gene can transiently express high levels of AGAR activity in several tissues without ovcrt toxicity from the recombinant protein. Ovcrexpression of AGAR in the liver was associated with a substantial increase in the rate of hepalic dcacylation of mdiolabeled rough-form LPS in vivo without a discernible impact on LPS plasma clearance. In addition, plasma levels of AOAR activity were significantly increased, yet increased LPS deacylation in plasma was not detected. Although intcrpretation of these data is complicated by several technical limitations, as noted above, the studies represent an initial step toward determining the roles of AOAR and LPS deacyJation in animals. Efforts to augment AOAH expressiou in phagocytic cells and to eliminate AOAR expression by targeted disruption of the murine AGAR gene should providc more definitive insights regarding thc role of this enzyme, and its products, in vivo.
